19 Nov 2026, 09:37
Presentations—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 19 Nov 2026, 09:37 | Bell Potter Healthcare Conference Presentation | Presentations | — | 03026 | |
| 16 Nov 2026, 09:40 | Update - Proposed issue of securities - NUZ | Securities Administration | — | 06013 | |
| 16 Nov 2026, 09:35 | Update - Proposed issue of securities - NUZ | Securities Administration | — | 06013 | |
| 16 Nov 2026, 09:30 | Notice of General Meeting/Proxy Form | Presentations | — | 08004, 08007, 14014, 16002 | |
| 16 Nov 2026, 09:00 | Prospectus | Securities Administration | — | 06009, 06010 | |
| 16 Nov 2026, 08:50 | Share Purchase Plan and Options Offer Open | Capital Raising | MS | 06003, 06017 | |
| 13 Nov 2026, 09:39 | First Regimen I patient enters Active Treatment Extension | Company Update | MS | 11001 | |
| 13 Nov 2026, 09:29 | R&D Facility Extension and Second Drawdown Completed | Capital Raising | — | 03022 | |
| 11 Nov 2026, 11:21 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 9 Nov 2026, 09:35 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 9 Nov 2026, 09:21 | Application for quotation of securities - NUZ | Securities Administration | — | 06020 | |
| 9 Nov 2026, 09:18 | Application for quotation of securities - NUZ | Securities Administration | — | 06020 | |
| 6 Nov 2026, 10:56 | Application for quotation of securities - NUZ | Securities Administration | — | 06020 | |
| 5 Nov 2026, 09:58 | Investor webinar reminder and presentation | Capital Raising | — | 03026, 06003, 06017, 14014 | |
| 2 Nov 2026, 09:55 | Notification of cessation of securities - NUZ | Securities Administration | — | 06027 | |
| 2 Nov 2026, 09:42 | Withdrawal of Resolution 4 from Notice of AGM | Meetings & Governance | — | 08005 | |
| 2 Nov 2026, 09:38 | Redemption of all remaining Obsidian convertible notes | Securities Administration | MS | 06009 | |
| 2 Nov 2026, 09:33 | Proposed issue of securities - NUZ | Securities Administration | — | 06013 | |
| 2 Nov 2026, 09:32 | Proposed issue of securities - NUZ | Securities Administration | — | 06013 | |
| 2 Nov 2026, 09:32 | Firm commitments to raise A$4.3m and announcement of SPP | Capital Raising | MS | 06003, 06017, 09014, 14014 | |
| 29 Oct 2026, 09:21 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 28 Oct 2026, 09:36 | Appendix 4C & Quarterly Update | Quarterly Reports | MS | 19001, 19006 | |
| 26 Oct 2026, 16:56 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004, 16002 | |
| 23 Oct 2026, 09:09 | Change of AGM Date | Meetings & Governance | — | 08006 | |
| 13 Oct 2026, 16:37 | Notification of cessation of securities - NUZ | Securities Administration | — | 06027 | |
| 7 Oct 2026, 10:04 | Updated Investor Presentation and Webinar Reminder | Presentations | — | 03026, 14014 | |
| 6 Oct 2026, 09:57 | FDA Type C Feedback, HEALEY trial potentially registrational | Company Update | MS | 11001 | |
| 1 Oct 2026, 09:30 | Dr Chris Bremer commences as Neurizon CEO | Presentations | — | 14014 | |
| 17 Sept 2026, 13:59 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 15 Sept 2026, 18:17 | Notification of cessation of securities - NUZ | Securities Administration | — | 06027 | |
| 10 Sept 2026, 09:53 | Neurizon Announces Partial Redemption of Convertible Notes | Securities Administration | MS | 06009 | |
| 10 Sept 2026, 09:18 | Application for quotation of securities - NUZ | Securities Administration | — | 06020 | |
| 9 Sept 2026, 09:55 | NIH funds Expanded Access Program for NUZ-001 in ALS | Company Update | MS | 11001 | |
| 7 Sept 2026, 09:02 | Neurizon Appoints Chief Executive Officer | Company Administration | MS | 12019 | |
| 26 Aug 2026, 11:49 | Application for quotation of securities - NUZ | Securities Administration | — | 06020 | |
| 25 Aug 2026, 15:03 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 25 Aug 2026, 14:58 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 24 Aug 2026, 17:06 | Notification regarding unquoted securities - NUZ | Securities Administration | — | 06021 | |
| 13 Aug 2026, 09:46 | Elanco representative appointed as Neurizon Board Observer | Company Administration | — | 12008 | |
| 11 Aug 2026, 09:47 | Neurizon Completes Initial Drawdown under R&D Facility | Capital Raising | — | 03022 | |
| 31 July 2026, 15:32 | Appendix 4C & Quarterly Update | Quarterly Reports | MS | 19004, 19009 | |
| 31 July 2026, 15:21 | Neurizon Enters Strategic R&D Financing Facility | Capital Raising | MS | 03022 | |
| 29 July 2026, 13:56 | Melbourne investor briefing presentation | Presentations | — | 03026 | |
| 17 July 2026, 09:25 | HEALEY Enrolment Complete - Topline Accelerated to Q2 CY27 | Company Update | MS | 11001 | |
| 16 July 2026, 11:39 | Application for quotation of securities - NUZ | Securities Administration | — | 06020 | |
| 14 July 2026, 16:36 | Notification of cessation of securities - NUZ | Securities Administration | — | 06027 | |
| 2 July 2026, 09:20 | Neurizon Invites Investors to Melbourne Briefing | Company Administration | — | 12008 | |
| 1 July 2026, 09:48 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 30 June 2026, 09:13 | Proposed issue of securities - NUZ | Securities Administration | — | 06013 | |
| 29 June 2026, 16:31 | Notification of cessation of securities - NUZ | Securities Administration | — | 06027 |